Converging InformationTechnology & Automation Teams - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Converging InformationTechnology & Automation Teams
Getting IT, engineering, and manufacturing on the same page requires a delicate balance.


Pharmaceutical Technology


Taking tips from the field

Companies already implementing integration plans suggest the following:

  • Develop guiding principles of design and let these principles drive technology blueprints that are reviewed annually for investment requirements
  • Conduct peer-reviews of designs and project plans; don't assume that because you have a technology blueprint or template that it will be followed
  • Realize that convergence is easier to achieve with senior management support and a clear vision of expected results
  • Develop a method for best-practice feedback; conduct post-mortems at the end of each project to discuss whether standards, policies or procedures need to be revised
  • Ensure an equal balance of involvement of IT and plant-floor staff in the process
  • Formalize the change-management and change-control process for all plant-floor modifications (e.g., description, authorization, testing, back-out plan)
  • Find a way to make the necessary investments in technology standards.

Integration of control and information systems in manufacturing requires end-to-end understanding of the problems your company is trying to solve. With the right mindset, you can get halfway there. Manufacturers can successfully navigate potential challenges by balancing the right technology, solid leadership, open communication, and outside help. While a transformation of this magnitude can take an enormous amount of time and effort, the long-term returns will continue to pay off year after year.

Julie Fraser is a principal & industry analyst at Industry Directions Inc. and Matt Bauer is director of commercial marketing for Rockwell Software at Rockwell Automation, 415 Eagleview Blvd., Suite 119, Exton, PA, 19341, 610.524.8391,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here